State of the Art Symposium
Immunotherapy for cancer: do patients need targeted imaging?
Lectures
1
Chairperson's introduction - Clarisse Dromain, Lausanne / CH
05:00
2
Immunotherapy: an oncologist's view - Dirk De Ruysscher, Maastricht / NL
18:00
3
Standard imaging: limitations in assessing immunotherapy? - Clarisse Dromain, Lausanne / CH
18:00
4
Molecular and hybrid imaging: what should we target? - Egesta Lopci, Rozzano / IT
18:00
5
Predicting response to cancer immunotherapy using radiomics and artificial intelligence - Stefano Trebeschi, Amsterdam / NL
18:00
